Classification and staging of melanoma

Hematology/Oncology Clinics of North America

Volumn 12, Issue 4, 1998, Pages 737-765

  Gershenwald, J E ^a   Buzaid, A C ^a   Ross, M I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER STAGING; EARLY DIAGNOSIS; HEALTH CARE QUALITY; HUMAN; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0031661751     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70021-6     Document Type: Article

References (115)

1. Ackerman L. Del Regato J. Cancer Diagnosis, Treatment and Prognosis 1947 CV Mosby St. Louis 169 181
2. J. Albertini C. Cruse D. Rapaport Intraoperative radiolymphoscintigraphy >improves sentinel lymph node identification for patients with melanoma Ann Surgery 223 1996 217 224
3. A. Allen S. Spitz Malignant melanoma. A clinicopathological analysis of the criteria for diagnosis and prognosis Cancer 6 1953 1 45
4. American Joint Committee for Cancer Staging and End-Results Reporting Staging of malignant melanoma Manual for Staging of Cancer 1977 1977 American Joint Committee Chicago 131 140
5. American Joint Committee for Cancer Staging and End-Results Reporting Staging of malignant melanoma Manual for Staging of Cancer 1978 1978 American Joint Committee Chicago 131 140
6. American Joint Committee on Cancer Melanoma of the skin Beahrs O. Myers M. Manual for Staging of Cancer 1983 JB Lippincott Philadelphia 117 120
7. American Joint Committee on Cancer Melanoma of the skin Beahrs O. Henson D. Hutter R. Myers M. Manual for Staging of Cancer 1988 JB Lippincott Philadelphia 140 142
8. American Joint Committee on Cancer Malignant melanoma of the skin Beahrs O. Henson D. Hutter R. Kennedy B. Manual for Staging of Cancer 1992 JB Lippincott Philadelphia 143 148
9. American Joint Committee on Cancer Malignant melanoma of the skin Fleming I. Cooper J. Henson D. AJCC Cancer Staging Manual 1997 Lippincott-Raven Philadelphia 163 170
10. A. Ardizzoni A. Grimaldi L. Repetto Stage I-II melanoma: The value of metastatic work-up Oncology 44 1987 87 89
11. F. Au W. Maier L. Malmud Preoperative nuclear scans in patients with melanoma Cancer 53 1984 2095 2097
12. C. Balch Cutaneous melanoma: Prognosis and treatment results worldwide Semin Surg Oncol 8 1992 400 414
13. C. Balch T. Murad S. Soong A multifactorial analysis of melanoma: Prognostic histopathological features comparing Clark's and Breslow's staging methods Ann Surg 188 1978 732 742
14. Balch C. Soong S.-J. T. Murad A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II) Ann Surg 193 1981 377 388
15. Balch C. Soong S.-J. H. Shaw An analysis of prognostic factors in 8500 patients with cutaneous melanoma Balch C. Houghton A. Milton G. Cutaneous Melanoma 1992 JB Lippincott Philadelphia 165 189
16. A. Barth L. Wanek D. Morton Prognostic factors in 1521 melanoma patients with distant metastases J Am Coll Surg 181 1995 193 201
17. Barth R. Jr D. Venzon A. Baker The prognosis of melanoma patients with metastases to two or more lymph node areas Ann Surg 214 1991 125 130
18. Z. Battayani J. Grob L. Xerri Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma Arch Dermatol 131 1995 443 447
19. M. Bengoechea-Beeby A. Velasco-Oses F. Fernandez Epidermotropic metastatic melanoma: Are the current histologic criteria adequate to differentiate primary from metastatic melanoma? Cancer 72 1993 1909 1913
20. R. Bevilacqua D. Coit A. Rogatka Axillary dissection in melanoma: Prognostic variables in node-positive patients Ann Surg 212 1990 125 131
21. A. Breslow Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma Ann Surg 172 1970 902 908
22. A. Breslow N. Cascinelli Van der Esch E. A. Morabito Stage I melanoma of the limbs: Assessment of prognosis by levels of invasion and maximum thickness Tumori 64 1978 273 284
23. P. Brossart U. Keiholz M. Willhauck Hematogenous spread of malignant melanoma cells in different stages of disease J Invest Dermatol 101 1993 887 889
24. P. Brossart J. Schmier S. Krüger A polymerase chain reaction–based semiquantitative assessment of malignant melanoma cells in peripheral blood Cancer Res 55 1995 4065 4068
25. C. Brown J. Zitelli The prognosis and treatment of true local cutaneous recurrent malignant melanoma Dermatol Surg 21 1995 285 290
26. P. Büttner C. Garbe J. Bertz Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification Cancer 75 1995 2499 2506
27. A. Buzaid M. Ross C. Balch Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system J Clin Oncol 15 1997 1039 1051
28. A. Buzaid A. Sandler S. Mani Role of computed tomography in the staging of primary melanoma J Clin Oncol 11 1993 638 643
29. A. Buzaid L. Tinoco D. Jendiroba Prognostic value of size of lymph node metastases in patients with cutaneous melanoma J Clin Oncol 13 1995 2361 2368
30. A. Buzaid L. Tinoco M. Ross The role of computed tomography in the staging of patients with local-regional metastases of melanoma J Clin Oncol 13 1995 2104 2108
31. A. Calabro S. Singletary C. Balch Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases Arch Surg 124 1989 1051 1055
32. C. Callery A. Cochran D. Roe Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes Ann Surg 196 1982 69 75
33. N. Cascinelli R. Bufalino R. Marolda Regional non-nodal metastases of cutaneous melanoma Eur J Surg Oncol 12 1986 175 180
34. N. Cascinelli R. Bufalino A. Morabito R. MacKie Results of adjuvant interferon study in WHO melanoma programme Lancet 343 1994 913 914
35. N. Cascinelli M. Vaglini M. Nava Prognosis of skin melanoma with regional node metastases (Stage II) Surg Oncol 25 1984 240 247
36. Clark W. Jr L. From E. Bernardino M. Mihm The histogenesis and biologic behavior of primary human malignant melanomas of the skin Cancer Res 29 1969 705 726
37. A. Cochran C. Bailly E. Paul F. Remotti Melanocytic Tumors: A Guide to Diagnosis. Biopsy Interpretation Series 1997 Lippincott-Raven Philadelphia
38. M. Cohen A. Ketcham E. Felix Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma Ann Surg 186 1977 635 642
39. D. Coit Prognostic factors in patients with melanoma metastatic to regional nodes Surg Oncol Clin North Am 1 1992 281 295
40. D. Coit M. Brennan Extent of lymph node dissection in melanoma of the trunk or lower extremity Arch Surg 124 1989 162 166
41. D. Coit A. Rogatko M. Brennan Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis Ann Surg 214 1991 627 636
42. D. Coit P. Sauven M. Brennan Prognosis of thick cutaneous melanoma of the trunk and extremity Arch Surg 125 1990 322 326
43. D. Coit M. Wallack C. Balch Society of surgical oncology practice guidelines: Melanoma surgical practice guidelines Oncology 11 1997 1317 1323
44. E. Creagan R. Dalton D. Ahmann Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma J Clin Oncol 13 1995 2776 2783
45. N. Crowley H. Seigler The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma Cancer 66 1990 2522 2527
46. P. Dale L. Foshag L. Wanek D. Morton Metastasis of primary melanoma to two separate lymph node basins: Prognostic significance Ann Surg Oncol 4 1997 13 18
47. D. Damian M. Fulham E. Thompson J. Thompson Positron emission tomography in the detection and management of metastatic melanoma Melanoma Res 6 1997 325 329
48. C.J. Day T. Harrist F. Gorstein Malignant melanoma: Prognostic significance of “microscopic satellites” in the reticular dermis and subcutaneous fat Ann Surg 194 1981 108 112
49. C.J. Day A. Sober R. Lew Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes Cancer 47 1981 955 962
50. H. Drepper B. Bieβ B. Hofherr M. Hundiker The prognosis of patients with stage III melanoma Cancer 71 1993 1239 1246
51. K. Drzewiecki A. Andersson Local melanoma recurrences in the scar after limited surgery for primary tumor World J Surg 19 1995 346 349
52. O. Eton S. Legha T. Moon Prognostic factors for survival of patients treated systemically for disseminated melanoma J Clin Oncol 16 1998 1103 1111
53. R. Evans K. Bland M. McMurtrey A. Ballantyne Radionuclide scans not indicated for clinical stage I melanoma Surg Gynecol Obstet 150 1980 532 534
54. S. Finck A. Giuliano B. Mann D. Morton Results of ilioinguinal dissection for stage II melanoma Ann Surg 196 1982 180 186
55. J. Fortner R. Booher G. Pack Results of groin dissection for malignant melanoma in 220 patients Surgery 55 1964 485 494
56. A. Foss M. Guille N. Occleston The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction Br J Cancer 72 1995 155 159
57. Gershenwald J, Thompson W, Mansfield P, et al: Patterns of failure in melanoma patients after successful lymphatic mapping and negative sentinel node biopsy. In 49th Annual Meeting of The Society of Surgical Oncology, Atlanta, 1996
58. Gershenwald J, Tseng C-h, Thompson W, et al: Improved sentinel lymph node localization in primary melanoma patients with the use of radio labeled colloid. Surgery, in press
59. R. Glaser K. Rass S. Seiter Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study J Clin Oncol 15 1997 2818 2825
60. A. Häffner C. Garbe G. Burg The prognosis of primary and metastasing melanoma. An evaluation of the TNM classification in 2495 patients Br J Cancer 66 1992 856 861
61. T. Harrist D. Rigel Day C. Jr “Microscopic satellites” are more highly associated with regional lymph node metastases than with primary melanoma thickness Cancer 53 1984 2183 2187
62. D. Hoon Y. Wang P. Dale Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay J Clin Oncol 13 1995 2109 2116
63. Hurt M. Santa Cruz D. Malignant melanoma microstaging: History, premises, methods, problems, and recommendations—a call for standardization Pathol Annu 29 1994 51 74
64. T. Johnson D. Fader A. Chang Computed tomography in staging of patients with melanoma metastatic to the regional nodes Ann Surg Oncol 4 1997 396 402
65. F. Jung A. Buzaid M. Ross Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients J Clin Oncol 15 1997 2826 2831
66. C. Karakousis D. Driscoll Groin dissection in malignant melanoma Bri J Surg 81 1994 1771 1774
67. C. Karakousis W. Goumas U. Rao D. Driscoll Axillary node dissection in malignant melanoma Am J Surg 162 1991 202 207
68. C. Karakousis M. Hena L. Emrich D. Driscoll Axillary node dissection in malignant melanoma: Results and complications Surgery 108 1990 10 17
69. C. Karakousis M. Seddip R. Moore Prognostic value of lymph node dissection in malignant melanoma Arch Surg 115 1980 719 722
70. C. Karakousis D. Temple R. Moore J. Ambrus Prognostic parameters in recurrent malignant melanoma Cancer 52 1983 575 579
71. A. Ketcham F. Moffat C. Balch Classification and staging Balch C. Houghton A. Milton G. Cutaneous Melanoma 1992 JB Lippincott Philadelphia 213 220
72. T. Khansur J. Sanders S. Das Evaluation of staging work-up in malignant melanoma Arch Surg 124 1989 847 849
73. J. Kirkwood M. Strawderman M. Ernstoff Interferon-alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684 J Clin Oncol 14 1996 7 17
74. M. Kissin D. Simpson D. Easton Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma Br J Surg 74 1987 1023 1026
75. H. Koh A. Sober C.J. Day Prognosis of clinical stage I melanoma patients with positive elective regional node dissection J Clin Oncol 4 1986 1238 1244
76. I. Kostrubiak N. Whitley J. Aisner The use of computed body tomography in malignant melanoma JAMA 259 1988 2896 2897
77. D. Krag S. Meijer D. Weaver Minimal-access surgery for staging of melanoma Arch Surg 130 1995 654 658
78. U. Kunter J. Buer M. Probst Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma J Natl Cancer Inst 88 1996 590 594
79. B. Kuvshinoff C. Kurtz D. Coit Computed tomography in evaluation of patients with stage III melanoma Ann Surg Oncol 4 1997 252 258
80. P. León J. Daly M. Synnestvedt The prognostic implications of microscopic satellites in patients with clinical stage I melanoma Arch Surg 126 1991 1461 1468
81. R.H. Lund M. Inhen Malignant melanoma: Clinical and pathologic analysis of 93 cases Is prophylactic lymph node dissection indicated? Surgery 38 1955 652 659
82. J.H. McCarthy F. Herter The role of groin dissection in the management of melanoma of the lower extremity Ann Surg 179 1974 156 159
83. V. McGovern The classification of melanoma and its relationship with prognosis Pathology 2 1970 85 89
84. McNeer G. Das Gupta T. Prognosis in malignant melanoma Surgery 56 1964 512 518
85. J. Mehnert J. Heard Staging of malignant melanoma by depth of invasion Am J Surg 110 1965 168 176
86. B. Mellado D. Colomer T. Castel Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis J Clin Oncol 14 1996 2091 2097
87. D. Morton D. Davtyan L. Wanek Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness Cancer 71 1993 3737 3743
88. D. Morton L. Wanek L. Nizze Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes Ann Surg 214 1991 491 499
89. D. Morton D. Wen J. Wong Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 1992 392 399
90. N. Petersen D. Bodenham O. Lloyd Malignant melanomas of the skin Br J Plast Surg 15 1962 49 94
91. K. Pittman S. Burchill B. Smith Reverse transcriptase–polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood Ann Oncol 7 1996 297 301
92. N. Provost A. Marghoob A. Kopf Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: A survey of experienced physicians J Am Acad Dermatol 36 1997 711 720
93. D. Reintgen C. Balch J. Kirkwood M. Ross Recent advances in the care of the patient with malignant melanoma Ann Surg 225 1997 1 14
94. D. Reintgen C. Cruse K. Wells The orderly progression of melanoma nodal metastases Ann Surg 220 1994 759 767
95. D. Reintgen R. Vollmer C. Tso H. Seigler Prognosis for recurrent stage I malignant melanoma Arch Surg 122 1987 1338 1342
96. D. Roses N. Karp R. Oratz Survival with regional and distant metastases from cutaneous malignant melanoma Surg Gynecol Obstet 172 1991 262 268
97. D. Roses J. Provet M. Harris Prognosis of patients with pathologic Stage II cutaneous malignant melanoma Ann Surg 201 1985 103 107
98. C. Rossi A. Seno A. Vecchiato The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma Eur J Cancer 33 1997 200 203
99. J. Roth F. Eilber L. Bennett D. Morton Radionuclide photoscanning. Usefulness in preoperative evaluation of melanoma patients Arch Surg 110 1975 1211 1212
100. S. Singletary R. Shallenberger V. Guinee Surgical management of groin nodal metas tases from primary melanoma of the lower extremity Surg Gynecol Obstet 174 1992 195 200
101. S. Singletary R. Shallenberger V. Guinee C. McBride Melanoma with metastasis to regional axillary or inguinal lymph nodes: Prognostic factors and results of surgical treatment in 714 patients South Med J 81 1988 5 9
102. S. Singletary S. Tucker A. Boddie Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma Cancer 61 1988 1437 1440
103. M. Sirott D. Bajorin G. Wong Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis Cancer 72 1993 3091 3098
104. C.J. Slingluff R. Vollmer H. Seigler Stage II malignant melanoma: Presentation of a prognostic model and an assessment of specific active immunotherapy in 1273 patients J Surg Oncol 39 1988 139 147
105. B. Smith P. Selby J. Southgate Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction Lancet 338 1991 1227 1229
106. J Smith, Histopathology and biological behavior of melanoma, Neoplasms of the Skin and Malignant Melanomas: A Collection of Papers Presented at the twentieth Annual Clinical Conference on Cancer, 1975, at The University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, Texas. Chicago, Year Book Medical Publishers, 1976, p 293.
107. C. Sutherland F. Mather E. Krementz Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion Surg Gynecol Obstet 164 1987 111 118
108. J. Thomas D. Panaussopoulos G. Liesmann Scintiscans in the evaluation of patients with malignant melanoma Surg Gynecol Obstet 149 1979 574 576
109. J. Thompson W. McCarthy C. Bosch Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes Melanoma Res 5 1995 255 260
110. Thompson W, Gershenwald J, Lee J, et al: Sentinel lymph node identification in melanoma patients using two techniques: Dye vs. dye + radiolabeled colloid. In 49th Annual Meeting of The Society of Surgical Oncology, Atlanta, 1996
111. R. Uren R. Howman-Giles J. Thompson Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma Melanoma Res 4 1994 395 399
112. M. Urist C. Balch G. Milton Surgical management of the primary melanoma Balch C. Milton G. Cutaneous Melanoma. Clinical Management and Treatment Results Worldwide 1985 JB Lippincott Philadelphia 71
113. P. Valk T. Pounds R. Tesar Cost-effectiveness of PET imaging in clinical oncology Nucl Med Biol 23 1996 737 743
114. R. Vollmer Malignant melanoma. A multivariate analysis of prognostic factors Pathol Annu 24 1989 383 407
115. G. Zartman M. Thomas W. Robinson Metastatic disease in patients with newly diagnosed malignant melanoma J Surg Oncol 35 1987 163 164